Chinese Journal Of Clinical Anatomy ›› 2018, Vol. 36 ›› Issue (1): 38-44.doi: 10.13418/j.issn.1001-165x.2018.01.010

Previous Articles     Next Articles

The effects of edaravone combined with breviscapine treatment on MCP-1 expression in the cerebral cortex after focal cerebral ischemia in rats

LI Fan1, CHEN Wei-wei2, ZHAO Xiao-shu3, ZENG Hong-yan3, HAN Hong2, SONG Yong-li2, YUAN Yun2, WU Chun-yun2   

  1. 1. Department of Experiment Center for Medical Science Research; 2. Department of Anatomy/Histology and Embryology, Kunming Medical University, Kunming 650500;3. Kunming Medical University Haiyuan College, Kunming 651701, China
  • Received:2017-09-13 Online:2018-01-25 Published:2018-03-06

Abstract:

Objective This research investigated the expression of MCP-1 in cerebral cortex of rat following middle cerebral artery occlusion (MCAO) and edaravone combination with breviscapine as a treatment of MCP-1 expression. Methods Animal models of MCAO were established, and RT-PCR,Western blot and Immunohistochemistry were used to detect the expression of MCP-1 in cerebral cortex of rats after MCAO and drug intervention.  Results  The expression of MCP-1 mRNA were significantly enhanced after MCAO, and became most severe at 12 h, and the difference was significant (P<0.05). The expression of MCP-1 mRNA was markedly decreased compared with the saline group after drug treatment (P<0.05); The combination of edaravone plus breviscapine was more effective than edaravone or breviscapine  treatment alone (P<0.05). The expression of MCP-1 protein was significantly increased in 1d, 3d, 1 week following MCAO and stayed at a high level (P<0.05), and than obviously decreased compared with the saline group after drug treatment (P<0.05); the combination of edaravone plus breviscapine was more effective than edaravone or breviscapine alone (P<0.05) . Immunofluorescence staining showed that activated microglial cells was co-labeled with MCP-1 positive cells, and the number of MCP-1 positive cells was significantly increased after MCAO peaking at 1week. By the mean time, microglial cells did not exhibit MCP-1 positive cells in saline group. Conclusion Edaravone combination with breviscapine as a treatment could decrease the MCP-1 expression after cerebral ischemia, and the combination of edaravone plus breviscapine is more effective than edaravone or breviscapine alone.

Key words: Cerebral ischemia; Breviscapine; Edaravone; Monocyte chemotactic protein 1,  Rats